BFA
SNDX icon

BlackRock Fund Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

BlackRock Fund Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.09M Buy
151,781
+21,418
+16% +$235K ﹤0.01% 3222
2016
Q3 		$1.98M Buy
130,363
+6,691
+5% +$88K ﹤0.01% 3160
2016
Q2 		$1.22M Buy
+123,672
New +$1.7M ﹤0.01% 3248

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock Fund Advisors's SNDX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Syndax Pharmaceuticals (SNDX) stake by 16% in Q4 2016, buying an estimated $235K and bringing the position to 151,781 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

BlackRock Fund Advisors first reported a position in SNDX in Q2 2016 and has held it in 3 quarters since. The position peaked at $1.98M in Q3 2016. 57 funds tracked by Wall St. Rank hold SNDX as of Q4 2016.

  • BlackRock Fund Advisors held 151,781 shares of Syndax Pharmaceuticals worth $1.09M as of Q4 2016.
  • BlackRock Fund Advisors bought 21,418 Syndax Pharmaceuticals shares in Q4 2016, an estimated $235K.
  • Syndax Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3222 holding.
  • BlackRock Fund Advisors first reported a position in Syndax Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Fund Advisors's Syndax Pharmaceuticals position peaked at $1.98M in Q3 2016.
  • 57 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.